Selenomethionine suppresses head and neck squamous cell carcinoma progression through TopBP1/ATR and TCAB1 signaling

Bo Zhang1,2, Xiaodong Wei3,4, Jiwu Li5

  • 1Hubei Provincial Key Laboratory of Occurrence and Intervention of Rheumatic Diseases, Hubei Minzu University, Enshi City, Hubei Province, China. zhboss1234@163.com.

Histology and Histopathology
|September 26, 2023
PubMed
Abstract

Insights

L-selenomethionine (SeMet) inhibits head and neck squamous cell carcinoma (HNSCC) cell survival and proliferation while promoting apoptosis. This occurs by modulating the TopBP1/ATR and TCAB1 signaling pathways, suggesting SeMet as a potential HNSCC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Head and neck squamous cell carcinoma (HNSCC) is a prevalent cancer.
  • Selenium compounds, including L-selenomethionine (SeMet), show promise in cancer therapy.
  • Understanding the molecular mechanisms of SeMet in HNSCC is crucial for therapeutic development.

Purpose of the Study:

  • To elucidate the mechanism by which L-selenomethionine (SeMet) exerts its anti-cancer effects in head and neck squamous cell carcinoma (HNSCC).
  • To investigate the role of TopBP1/ATR and TCAB1 signaling pathways in SeMet-mediated HNSCC treatment.

Main Methods:

  • Cell viability and proliferation were assessed using MTT and colony formation assays.
  • Apoptosis was evaluated via TUNEL staining.
  • Gene and protein expression levels were quantified using qRT-PCR and Western blotting, respectively.

Main Results:

  • SeMet significantly reduced HNSCC cell survival and proliferation in a dose- and time-dependent manner.
  • SeMet treatment upregulated TopBP1, ATR, H2AX, p-ATR, and γ-H2AX, while downregulating TCAB1.
  • The effects of SeMet were partially reversed by manipulating TopBP1 and TCAB1 expression, indicating their critical roles in the observed outcomes.

Conclusions:

  • L-selenomethionine (SeMet) effectively inhibits HNSCC proliferation and induces apoptosis.
  • The mechanism involves the modulation of TopBP1/ATR signaling activation and TCAB1 expression.
  • SeMet represents a potential therapeutic agent for head and neck squamous cell carcinoma.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K